Therapeutic Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.12 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -41.99%
- Profit Growth -43.21%
- Ebitda 212.86%
- Net Worth -8.12%
- Total Assets -2.57%
About Therapeutic Bioceuticals
Therapeutic Bioceuticals Private Limited (TBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2013 and has a history of 11 years and 11 months. Its registered office is in Kapurthala, Punjab, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Harjit Joshi, Varinder Kumar, Radha Joshi, and One other member serve as directors at the Company.
Company Details
-
Location
Kapurthala, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232PB2013PTC037088
-
Company No.
037088
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Feb 2013
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Therapeutic Bioceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varinder Kumar
|
Managing Director | 11-Feb-2013 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Harjit Joshi
|
Director | 11-Feb-2013 | Current |
|
Radha Joshi
|
Director | 25-Apr-2018 | Current |
|
Mamta Joshi
|
Director | 25-Apr-2018 | Current |
Financial Performance of Therapeutic Bioceuticals.
Therapeutic Bioceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 41.99% decrease. The company also saw a substantial fall in profitability, with a 43.21% decrease in profit. The company's net worth dipped by a decrease of 8.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Therapeutic Bioceuticals?
In 2017, Therapeutic Bioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Therapeutic Bioceuticals?
Unlock and access historical data on people associated with Therapeutic Bioceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therapeutic Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therapeutic Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
